- Home
- PHVS vs ACDC Comparison
PHVS vs ACDC Comparison
Compare PHVS & ACDC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PHVS | ACDC |
|---|---|---|
| Founded | 2015 | 2014 |
| Country | Switzerland | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Oilfield Services/Equipment |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 703.6M |
| IPO Year | 2021 | 2022 |
Fundamental Metrics
Financial Performance| Metric | PHVS | ACDC |
|---|---|---|
| Price | $27.08 | $3.80 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 9 | 3 |
| Target Price | ★ $39.44 | $5.83 |
| AVG Volume (30 Days) | 532.0K | ★ 1.3M |
| Earning Date | 11-12-2025 | 11-10-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $1,960,000,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $11.51 | $3.08 |
| 52 Week High | $29.80 | $10.70 |
Technical Indicators
Market Signals| Indicator | PHVS | ACDC |
|---|---|---|
| Relative Strength Index (RSI) | 58.17 | 43.96 |
| Support Level | $23.79 | $3.78 |
| Resistance Level | $25.44 | $4.01 |
| Average True Range (ATR) | 1.82 | 0.29 |
| MACD | 0.00 | -0.03 |
| Stochastic Oscillator | 59.12 | 15.50 |
Price Performance
Historical ComparisonAbout PHVS Pharvaris N.V.
Pharvaris NV is a late-stage biopharmaceutical company which is engaged in developing novel, oral bradykinin B2 receptor antagonists to prevent and treat HAE attacks. By directly pursuing this clinically therapeutic target with novel small molecules, With positive data in both Phase 2 prophylaxis and studies in HAE, Pharvaris is developing deucrictibant. Pharvaris is currently enrolling a pivotal Phase 3 study for the treatment of HAE attacks and plans to initiate a pivotal Phase 3 study of deucrictibant for the prevention of HAE attacks.
About ACDC ProFrac Holding Corp.
ProFrac Holding Corp is engaged in providing hydraulic fracturing, completion services, and other complementary products and services to upstream oil and gas companies engaged in the exploration and production of North American unconventional oil and natural gas resources. The company operates in three segments: Stimulation Services, Proppant Production, and Manufacturing. Stimulation services, which generate the majority of the revenue for the company operate a fleet of mobile hydraulic fracturing units and other auxiliary equipment that generates revenue by providing stimulation services.